Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p53 expression in gestational trophoblastic disease

Y S Lee1

  • 1Department of Pathology, National University of Singapore, Republic of Singapore.

International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|April 1, 1995
PubMed
Summary

p53 protein expression is common in gestational trophoblastic diseases and normal cells, reflecting cell proliferation rather than malignancy. Caution is advised when interpreting p53 immunohistochemistry results.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in natural killer cell activity and prostaglandin E2 levels during the progression of diethylnitrosamine-induced hepatocarcinogenesis in Fischer 344 rats.

Oncology reports·1998
Same author

Time course of cell cycle-related protein expression in diethylnitrosamine-initiated rat liver.

Journal of hepatology·1998
Same author

A new preoperative immunochemotherapy for the treatment of locally advanced esophageal cancer.

Hepato-gastroenterology·1998
Same author

Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.

Cancer chemotherapy and pharmacology·1998
Same author

Two-step autocatalytic processing of the glutaryl 7-aminocephalosporanic acid acylase from Pseudomonas sp. strain GK16.

Journal of bacteriology·1998
Same author

Gender differences in baseline variables, therapies and outcomes in Chinese patients with acute myocardial infarction.

International journal of cardiology·1998

Area of Science:

  • Gynecologic Pathology
  • Cell Biology
  • Cancer Research

Background:

  • The p53 protein is a critical tumor suppressor involved in cell cycle regulation.
  • Immunohistochemistry is frequently used to assess p53 expression in various tissues.
  • Understanding p53 expression patterns in gestational trophoblastic diseases is important for diagnosis and prognosis.

Purpose of the Study:

  • To investigate the expression patterns of p53 protein in normal trophoblasts and different types of gestational trophoblastic diseases.
  • To determine if p53 expression correlates with proliferative activity or neoplastic transformation in these conditions.

Main Methods:

  • Immunohistochemical analysis of p53 expression was performed on tissue samples.
  • Samples included normal trophoblasts, partial moles, complete moles, and gestational choriocarcinoma.

Related Experiment Videos

  • Expression levels were compared across different gestational conditions.

    • Main Results:

    • p53 protein was frequently expressed in gestational choriocarcinoma and hydatidiform moles, particularly in cytotrophoblasts.
    • Syncytiotrophoblasts showed minimal p53 expression.
    • p53 expression was also observed in normal trophoblasts, endometrial glands, and decidual cells, indicating its presence in non-neoplastic conditions.
    • Complete moles exhibited greater p53 expression than partial moles, correlating with higher proliferative activity.

    Conclusions:

    • p53 expression in gestational trophoblastic tissues reflects cellular proliferative capacity rather than solely indicating malignancy.
    • The presence of p53 in normal and non-neoplastic conditions necessitates careful interpretation of immunohistochemical findings.
    • p53 immunohistochemistry should be considered alongside other diagnostic criteria for gestational trophoblastic diseases.